Disruption of Nrf2, a Key Inducer of Antioxidant Defenses, Attenuates ApoE-Mediated Atherosclerosis in Mice
Open Access
- 21 November 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (11), e3791
- https://doi.org/10.1371/journal.pone.0003791
Abstract
Oxidative stress and inflammation are two critical factors that drive the formation of plaques in atherosclerosis. Nrf2 is a redox-sensitive transcription factor that upregulates a battery of antioxidative genes and cytoprotective enzymes that constitute the cellular response to oxidative stress. Our previous studies have shown that disruption of Nrf2 in mice (Nrf2−/−) causes increased susceptibility to pulmonary emphysema, asthma and sepsis due to increased oxidative stress and inflammation. Here we have tested the hypothesis that disruption of Nrf2 in mice causes increased atherosclerosis. To investigate the role of Nrf2 in the development of atherosclerosis, we crossed Nrf2−/− mice with apoliporotein E-deficient (ApoE−/−) mice. ApoE−/− and ApoE−/− Nrf2−/− mice were fed an atherogenic diet for 20 weeks, and plaque area was assessed in the aortas. Surprisingly, ApoE−/− Nrf2−/− mice exhibited significantly smaller plaque area than ApoE−/− controls (11.5% vs 29.5%). This decrease in plaque area observed in ApoE−/− Nrf2−/− mice was associated with a significant decrease in uptake of modified low density lipoproteins (AcLDL) by isolated macrophages from ApoE−/− Nrf2−/− mice. Furthermore, atherosclerotic plaques and isolated macrophages from ApoE−/− Nrf2−/− mice exhibited decreased expression of the scavenger receptor CD36. Nrf2 is pro-atherogenic in mice, despite its antioxidative function. The net pro-atherogenic effect of Nrf2 may be mediated via positive regulation of CD36. Our data demonstrates that the potential effects of Nrf2-targeted therapies on cardiovascular disease need to be investigated.Keywords
This publication has 40 references indexed in Scilit:
- Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsisJCI Insight, 2006
- 12/15-Lipoxygenase gene disruption and Vitamin E administration diminish atherosclerosis and oxidative stress in apolipoprotein E deficient mice through a final common pathwayProstaglandins & Other Lipid Mediators, 2005
- CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearanceJournal of Lipid Research, 2005
- Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in miceThe Journal of Experimental Medicine, 2005
- Absence of heme oxygenase‐1 exacerbates atherosclerotic lesion formation and vascular remodelingThe FASEB Journal, 2003
- Induction of Glutathione Synthesis in Macrophages by Oxidized Low-Density Lipoproteins Is Mediated by Consensus Antioxidant Response ElementsCirculation Research, 2003
- Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not AtherosclerosisCirculation, 2002
- Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null miceJCI Insight, 2002
- Impaired Superoxide Production Due to a Deficiency in Phagocyte NADPH Oxidase Fails to Inhibit Atherosclerosis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- The role of oxidized lipoproteins in atherogenesisFree Radical Biology & Medicine, 1996